Skip to main content
Clinical Trials/CTIS2023-510186-98-00
CTIS2023-510186-98-00
Active, not recruiting
Phase 1

DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trial

Academisch Ziekenhuis Leiden0 sites10,078 target enrollmentApril 29, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Venous thromboembolism
Sponsor
Academisch Ziekenhuis Leiden
Enrollment
10078
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 29, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Subjects scheduled to undergo an elective Total Hip Arthroplasty or Total Knee Arthroplasty, Subjects aged 18 years or older

Exclusion Criteria

  • Primary arthroplasty for fractures, Patients using thrombocyte aggregation inhibitors that cannot be temporarily discontinued at the discretion of their treating physician, Revision surgery, Hemiarthroplasty, Pregnancy, Current use of therapeutic anticoagulant therapy of any type (e.g., LMWH, DOAC, vitamin K antagonist), A contraindication for either study drug, Insufficient knowledge of the Dutch language, Insufficient mental or physical ability to fulfil trial requirements, Active malignancy (i.e. cancer diagnosis within six months before surgery (excluding basal\-cell or squamous\-cell carcinoma of the skin), recently recurrent or progressive cancer or any cancer that required anti\-cancer treatment within six months before surgery)

Outcomes

Primary Outcomes

Not specified

Similar Trials